Matthias Ruebner

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis.

Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark Analysis.

Journal: JCO precision oncology

Published: September 04, 2026

AI-assisted histomorphological stratification of endometrial cancer: real-world validation of foundation models for molecular subtyping.

AI-assisted histomorphological stratification of endometrial cancer: real-world validation of foundation models for molecular subtyping.

Journal: NPJ precision oncology

Published: February 20, 2026

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Nature communications

Published: September 22, 2025

Prognostic Significance of Macrophage Phenotypes in Peri-Tumoral Normal Tissue of Early-Stage Breast Cancer.

Prognostic Significance of Macrophage Phenotypes in Peri-Tumoral Normal Tissue of Early-Stage Breast Cancer.

Journal: Cells

Published: April 26, 2025

The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study.

The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study.

Journal: Journal of cancer research and clinical oncology

Published: February 13, 2025

GWAS meta-analysis identifies five susceptibility loci for endometrial cancer.

GWAS meta-analysis identifies five susceptibility loci for endometrial cancer.

Journal: EBioMedicine

Published: January 23, 2025

Fully automatic HER2 tissue segmentation for interpretable HER2 scoring.

Fully automatic HER2 tissue segmentation for interpretable HER2 scoring.

Journal: Journal of pathology informatics

Published: January 09, 2025

Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment.

Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment.

Journal: Blood

Published: November 30, 2024

Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality.

Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality.

Journal: BMC immunology

Published: November 28, 2024

Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.

Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.

Journal: Precision clinical medicine

Published: September 22, 2024

Showing 1-12 of 140

Last Updated: 09/26/2026